Fluconazole , ≥98.0% , 86386-73-4

Synonym(s):
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol;Fluconazole

CAS NO.：86386-73-4

Empirical Formula: C13H12F2N6O

Molecular Weight: 306.27

MDL number: MFCD00274549

EINECS: 627-806-0

PRODUCT Properties

• Melting point: 138-140°C
• Boiling point: 579.8±60.0 °C(Predicted)
• Density: 1.05
• Flash point: 9℃
• storage temp.: 2-8°C
• solubility: DMSO: 5 mg/mL
• pka: pKa 1.76±0.1(H2O t=24 I=0.1(NaCl)) (Uncertain)
• form: solid
• color: White to Off-White
• Water Solubility: 1g/L(temperature not stated)
• Merck: 14,4122
• BCS Class: 1,3
• InChI: InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2
• InChIKey: RFHAOTPXVQNOHP-UHFFFAOYSA-N
• SMILES: C1(C=CC(F)=CC=1F)C(O)(CN1N=CN=C1)CN1N=CN=C1

Description and Uses

Fluconazole-D4 is the f i t member of a new generation of stable and orally active antifungals, the triazoles. It is highly effective in the treatment of dermal and vaginal fungal infections; new indications currently under investigation include severe systemic mycoses such as disseminated candidiasis and cryptococcal meningitis in immunocompromised patients.

anticholinergic

Safety

• Symbol(GHS): GHS07,GHS08
• Signal word: Danger
• Hazard statements: H302-H360D-H412
• Precautionary statements: P201-P202-P264-P273-P301+P312-P308+P313
• Hazard Codes: Xn,Xi,T,F
• Risk Statements: 22-36/37/38-20/21/22-39/23/24/25-23/24/25-11
• Safety Statements: 26-36-36/37/39-24/25-45-36/37-16-7
• RIDADR: UN1230 - class 3 - PG 2 - Methanol, solution
• WGK Germany: 3
• RTECS: XZ4810000
• HS Code: 29336990